The shorter, the better: A review of the evidence for a shorter contraceptive hormone-free interval

REFERENCES

• Critchley HO, Kelly RW, Brenner RM, et al. The endocrinology of menstruation – a role for the immune system. Clin Endocrinol (Oxf) 2001;55:701–10.
   PubMed Web of Science ®Google Scholar
• Menzies FM, Shepherd MC, Nibbs RJ, et al. The role of mast cells and their mediators in reproduction, pregnancy and labour. Hum Reprod Update 2011;17: 383–96.
   PubMed Web of Science ®Google Scholar
• Maybin JA, Critchley HO. Progesterone: A pivotal hormone at menstruation. Ann N Y Acad Sci 2011;1221: 88–97.
   PubMed Web of Science ®Google Scholar
• Berbic M, Fraser IS. Immunology of normal and abnormal menstruation. Women's Health (Lond Engl) 2013;9:387–95.
   PubMedGoogle Scholar
• Berbic M, Ng CH, Fraser IS. Inflammation and endometrial bleeding. Climacteric 2014;23:1–7.
   Google Scholar
• Lockwood CJ. Mechanisms of normal and abnormal endometrial bleeding. Menopause 2011;18:408–11.
   PubMed Web of Science ®Google Scholar
• Kirchhoff D, Kaulfuss S, Fuhrmann U, et al. Mast cells in endometriosis: Guilty or innocent bystanders? Expert Opin Ther Targets 2012;16:237–41.
   PubMed Web of Science ®Google Scholar
• Graziottin A. Contraception containing estradiol valerate and dienogest – Advantages, adherence and user satisfaction. Minerva Ginecol 2014;66:479–95.
   PubMedGoogle Scholar
• Graziottin A, Skaper SD, Fusco M. Inflammation and chronic pelvic pain: A biological trigger for depression in women? J Depress Anxiety 2013;3:142–50.
   Google Scholar
• Graziottin A, Skaper SD, Fusco M. Mast cells in chronic inflammation, pelvic pain and depression in women. Gynecol Endocrinol 2014;30:472–7.
   PubMed Web of Science ®Google Scholar
• Martin VT, Lipton RB. Epidemiology and biology of menstrual migraine. Headache 2008;48(Suppl. 3):S124–30.
   PubMed Web of Science ®Google Scholar
• Bertone-Johnson ER, Ronnenberg AG, Houghton SC, et al. Association of inflammation markers with menstrual symptom severity and premenstrual syndrome in young women. Hum Reprod 2014;29:1987–94.
   PubMed Web of Science ®Google Scholar
• Heitkemper MM, Cain KC, Jarrett ME, et al. Symptoms across the menstrual cycle in women with irritable bowel syndrome. Am J Gastroenterol 2003;98:420–30.
   PubMed Web of Science ®Google Scholar
• Sulak PJ, Scow RD, Preece C, et al. Hormone withdrawal symptoms in oral contraceptive users. Obstet Gynecol 2000; 95:261–6.
   PubMed Web of Science ®Google Scholar
• Willis SA, Kuehl TJ, Spiekerman AM, et al. Greater inhibition of the pituitary–ovarian axis in oral contraceptive regimens with a shortened hormone-free interval. Contraception 2006;74:100–3.
   PubMed Web of Science ®Google Scholar
• Witjes H, Creinin MD, Sundström-Poromaa I, et al. Comparative analysis of the effects of nomegestrol acetate/17β-estradiol and drospirenone/ethinylestradiol on premenstrual and menstrual symptoms and dysmenorrhea. Eur J Contracept Reprod Health Care 2015;20:296–307.
   PubMed Web of Science ®Google Scholar
• Klipping C, Duijkers I, Trummer D, et al. Suppression of ovarian activity with a drospirenone-containing oral contraceptive in a 24/4 regimen. Contraception 2008;78: 16–25.
   PubMed Web of Science ®Google Scholar
• Christin-Maitre S, Serfaty D, Chabbert-Buffet N, et al. Comparison of a 24-day and a 21-day pill regimen for the novel combined oral contraceptive, nomegestrol acetate and 17β-estradiol (NOMAC/E2): A double-blind, randomized study. Hum Reprod 2011;26:1338–47.
   PubMed Web of Science ®Google Scholar
• Micks E, Jensen JT. Estradiol valerate and dienogest: A novel four-phasic oral contraceptive pill effective for pregnancy prevention and treatment of heavy menstrual bleeding. Women's Health (Lond Engl) 2011;7:513–24.
   PubMedGoogle Scholar
• Micks EA, Jensen JT. Treatment of heavy menstrual bleeding with the estradiol valerate and dienogest oral contraceptive pill. Adv Ther 2013;30:1–13.
   PubMed Web of Science ®Google Scholar
• Jensen JT, Parke S, Mellinger U, et al. Hormone withdrawal-associated symptoms: comparison of oestradiol valerate/dienogest versus ethinylestradiol/norgestimate. Eur J Contracept Reprod Health Care 2013;18:274–83.
   PubMed Web of Science ®Google Scholar
• Macìas G, Merki-Feld GS, Parke S, et al. Effects of a combined oral contraceptive containing oestradiol valerate/dienogest on hormone withdrawal-associated symptoms: Results from the multicentre, randomised, double-blind, active-controlled HARMONY II study. J Obstet Gynaecol 2013;33:591–6.
   PubMedGoogle Scholar
• Nappi RE, Terreno E, Sances G, et al. Effect of a contraceptive pill containing estradiol valerate and dienogest (E2V/DNG) in women with menstrually-related migraine (MRM). Contraception 2013;88:369–75.
   PubMed Web of Science ®Google Scholar
• Nelson A, Parke S, Mellinger U, et al. Efficacy and safety of a combined oral contraceptive containing estradiol valerate/dienogest: Results from a clinical study conducted in North America. J Women's Health (Larchmt) 2014;23:204–10.
   PubMed Web of Science ®Google Scholar
• Thomas SL, Ellertson C. Nuisance or natural and healthy: Should monthly menstruation be optional for women? Lancet 2000;355(9207):922–4.
   PubMed Web of Science ®Google Scholar
• Bitzer J. Hormone withdrawal-associated symptoms: Overlooked and under-explored. Gynecol Endocrinol 2013;29:530–5.
   PubMed Web of Science ®Google Scholar
• Maybin JA, Critchley HO, Jabbour HN. Inflammatory pathways in endometrial disorders. Mol Cell Endocrinol 2011;335:42–51.
   PubMed Web of Science ®Google Scholar
• Evans J, Salamonsen LA. Inflammation, leukocytes and menstruation. Rev Endocr Metab Disord 2012;13:277–88.
   PubMed Web of Science ®Google Scholar
• Jabbour HN, Sales KJ, Catalano RD, et al. Inflammatory pathways in female reproductive health and disease. Reproduction 2009;138;903–19.
   PubMed Web of Science ®Google Scholar
• Dawood MY. Primary dysmenorrhea: Advances in pathogenesis and management. Obstet Gynecol 2006;108: 428–41.
   PubMed Web of Science ®Google Scholar
• Latthe P, Mignini L, Gray R, et al. Factors predisposing women to chronic pelvic pain: Systematic review. BMJ 2006;332(7544):749–55.
   PubMed Web of Science ®Google Scholar
• Hassan S, Muere A, Einstein G. Ovarian hormones and chronic pain: A comprehensive review. Pain 2014;155: 2446–60.
   PubMed Web of Science ®Google Scholar
• Brawn J, Morotti M, Zondervan KT, et al. Central changes associated with chronic pelvic pain and endometriosis. Hum Reprod Update 2014;20:737–47.
   PubMed Web of Science ®Google Scholar
• Miller AH, Maletic V, Raison CL. Inflammation and its discontents: The role of cytokines in the pathophysiology of major depression. Biol Psychiatry 2009;65:732–41.
   PubMed Web of Science ®Google Scholar
• Raison CL, Capuron L, Miller AH. Cytokines sing the blues: Inflammation and the pathogenesis of depression. Trends Immunol 2006;27:24–31.
   PubMed Web of Science ®Google Scholar
• Barbara G, Stanghellini V, De Giorgio R, et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 2004;126:693–702.
   PubMed Web of Science ®Google Scholar
• Dratva J, Schindler C, Curjuric I, et al. Perimenstrual increase in bronchial hyperreactivity in premenopausal women: Results from the population-based SAPALDIA 2 cohort. J Allergy Clin Immunol 2010;125: 823–9.
   PubMed Web of Science ®Google Scholar
• Galobardes B, Patel S, Henderson J, et al. The association between irregular menstruations and acne with asthma and atopy phenotypes. Am J Epidemiol 2012;176:733–7.
   PubMed Web of Science ®Google Scholar
• Svanes C, Real FG, Gislason T, et al. Association of asthma and hay fever with irregular menstruation. Thorax 2005;60:445–50.
   PubMed Web of Science ®Google Scholar
• Vandever MA, Kuehl TJ, Sulak PJ, et al. Evaluation of pituitary-ovarian axis suppression with three oral contraceptive regimens. Contraception 2008;77:162–70.
   PubMed Web of Science ®Google Scholar
• Baerwald AR1, Olatunbosun OA, Pierson RA. Ovarian follicular development is initiated during the hormone-free interval of oral contraceptive use. Contraception 2004;70:371–7.
   PubMed Web of Science ®Google Scholar
• Karlsson TS, Marions LB, Edlund MG. Heavy menstrual bleeding significantly affects quality of life. Acta Obstet Gynecol Scand 2014;93:52–7.
   PubMed Web of Science ®Google Scholar
• Wang W, Bourgeois T, Klima J, et al. Iron deficiency and fatigue in adolescent females with heavy menstrual bleeding. Haemophilia 2013;19:225–30.
   PubMed Web of Science ®Google Scholar
• Szarewski A, Mansour D, Shulman LP. 50 years of ‘The Pill’: celebrating a golden anniversary. J Fam Plann Reprod Health Care 2010;36:231–8.
   PubMed Web of Science ®Google Scholar
• Nakajima ST, Archer DF, Ellman H. Efficacy and safety of a new 24-day oral contraceptive regimen of norethindrone acetate 1 mg/ethinyl estradiol 20 micro g (Loestrin 24 Fe). Contraception 2007;75:16–22.
   PubMed Web of Science ®Google Scholar
• Spona J, Elstein M, Feichtinger W, et al. Shorter pill-free interval in combined oral contraceptives decreases follicular development. Contraception 1996; 54:71–7.
   PubMed Web of Science ®Google Scholar
• Chabbert-Buffet N. Synergistic effect of 17β-estradiol and nomegestrol acetate used in a new monophasic oral contraceptive. Paper presented at the 8th Congress of the European Society of Gynecology, Rome, Italy, 10–13 September 2009.
   Google Scholar
• Chabbert-Buffet N. Synergistic effect of 17β-estradiol and nomegestrol acetate used in a new monophasic oral contraceptive. Paper presented at the XIX FIGO World Congress of Gynecology and Obstetrics, Cape Town, South Africa, 4–9 October 2009.
   Google Scholar
• Kaunitz AM, Burkman RT, Fisher AC, et al. Cycle control with a 21-day compared with a 24-day oral contraceptive pill: A randomized controlled trial. Obstet Gynecol 2009; 114:1205–12.
   PubMed Web of Science ®Google Scholar
• Freeman EW, Halbreich U, Grubb GS, et al. An overview of four studies of a continuous oral contraceptive (levonorgestrel 90 mcg/ethinyl estradiol 20 mcg) on premenstrual dysphoric disorder and premenstrual syndrome. Contraception 2012;85:437–45.
   PubMed Web of Science ®Google Scholar
• De Berardis D, Serroni N, Salerno RM, et al. Treatment of premenstrual dysphoric disorder (PMDD) with a novel formulation of drospirenone and ethinyl estradiol. Ther Clin Risk Manag 2007;3: 585–90.
   PubMedGoogle Scholar
• Sulak PJ, Carl J, Gopalakrishnan I, et al. Outcomes of extended oral contraceptive regimens with a shortened hormone-free interval to manage breakthrough bleeding. Contraception 2004;70:281–7.
   PubMed Web of Science ®Google Scholar
• Bayer plc. Summary of product characteristics (SPC): Qlaira 2014. Accessed from: www.medicines.org.uk/emc/medicine/21700
   Google Scholar
• Fraser IS, Römer T, Parke S, et al. Effective treatment of heavy and/or prolonged menstrual bleeding with an oral contraceptive containing estradiol valerate and dienogest: A randomized, double-blind Phase III trial. Hum Reprod 2011;26:2698–708.
   PubMed Web of Science ®Google Scholar
• Jensen JT, Parke S, Mellinger U, et al. Effective treatment of heavy menstrual bleeding with estradiol valerate and dienogest: A randomized controlled trial. Obstet Gynecol 2011;117:777–87.
   PubMed Web of Science ®Google Scholar
• Fraser IS, Parke S, Mellinger U, et al. Effective treatment of heavy and/or prolonged menstrual bleeding without organic cause: Pooled analysis of two multinational, randomised, double-blind, placebo-controlled trials of oestradiol valerate and dienogest. Eur J Contracept Reprod Health Care 2011;16:258–69.
   PubMed Web of Science ®Google Scholar
• Vahdat Shariatpanaahi M, Vahdat Shariatpanaahi Z, Moshtaaghi M, et al. The relationship between depression and serum ferritin level. Eur J Clin Nutr 2007;61:532–5.
   PubMed Web of Science ®Google Scholar
• Murray-Kolb LE, Beard JL. Iron treatment normalizes cognitive functioning in young women. Am J Clin Nutr 2007;85:778–87.
   PubMed Web of Science ®Google Scholar
• Vaucher P, Druais PL, Waldvogel S, et al. Effect of iron supplementation on fatigue in nonanemic menstruating women with low ferritin: A randomized controlled trial. CMAJ 2012;184:1247–54.
   PubMed Web of Science ®Google Scholar
• Palacios S, Wildt L, Parke S, et al. Efficacy and safety of a novel oral contraceptive based on oestradiol (oestradiol valerate/dienogest): A phase III trial. Eur J Obstet Gynecol Reprod Biol 2010;149:57–62.
   PubMed Web of Science ®Google Scholar
• Rosenberg MJ, Waugh MS. Oral contraceptive discontinuation: A prospective evaluation of frequency and reasons. Am J Obstet Gynecol 1998;179(3 Pt 1):577–82.
   PubMed Web of Science ®Google Scholar
• Balassone ML. Risk of contraceptive discontinuation among adolescents. J Adolesc Health Care 1989;10:527–33.
   PubMedGoogle Scholar
• Berman JR. Physiology of female sexual function and dysfunction. Int J Impot Res 2005;17(1 Suppl.):S44–51.
   PubMed Web of Science ®Google Scholar
• Caruso S, Agnello C, Intelisano G, et al. Sexual behavior of women taking low-dose oral contraceptive containing 15 microg ethinylestradiol/60 microg gestodene. Contraception 2004;69:237–40.
   PubMed Web of Science ®Google Scholar
• Gulmez H, Akin Y, Savas M, et al. Impact of iron supplementation on sexual dysfunction of women with iron deficiency anemia in short term: A preliminary study. J Sex Med 2014;11:1042–6.
   PubMed Web of Science ®Google Scholar
• Unger EL, Wiesinger JA, Hao L, Beard JL. Dopamine D2 receptor expression is altered by changes in cellular iron levels in PC12 cells and rat brain tissue. J Nutr 2008;138:2487–94.
   PubMed Web of Science ®Google Scholar